Drug Type Oncolytic virus |
Synonyms |
Target |
Mechanism IL-12R stimulants(Interleukin-12 receptor stimulants), IL15R agonists(Interleukin-15 receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Virogin Biotech Ltd.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 1 | - | - | |
Breast Cancer | Preclinical | CA | Virogin Biotech Ltd.Startup | 27 Jul 2022 |
Ovarian Cancer | Preclinical | CA | Virogin Biotech Ltd.Startup | 27 Jul 2022 |
Renal Cell Carcinoma | Preclinical | CA | Virogin Biotech Ltd.Startup | 27 Jul 2022 |